منابع مشابه
Frequency of Abnormal Fecal Biomarkers in Irritable Bowel Syndrome
PRIMARY STUDY OBJECTIVE Determine the frequency of abnormal fecal biomarker test results in patients with 13 irritable bowel syndrome (IBS)-related ICD-9 (International Statistical Classification of Diseases and Related Health Problems) codes. STUDY DESIGN Quantitative review of de-identified records from patients in whom IBS was a possible diagnosis. METHODS Records were selected for analy...
متن کاملFeasibility of Fecal MicroRNAs as Novel Biomarkers for Pancreatic Cancer
INTRODUCTION Pancreatic cancer (PCA) is an aggressive tumor that associates with high mortality rates. Majority of PCA patients are diagnosed usually at late tumor stages when the therapeutic options are limited. MicroRNAs (miRNA) are involved in tumor development and are commonly dysregulated in PCA. As a proof-of-principle study, we aimed to evaluate the potential of fecal miRNAs as biomarker...
متن کاملFecal Biomarkers of Intestinal Health and Disease in Children
The identification of various fecal biomarkers has provided insight into the intestinal milieu. Most of these markers are associated with the innate immune system of the gut, apart from the more novel M2-pyruvate kinase. The innate immunity of the gut plays a role in maintaining a fine balance between tolerance to commensal bacteria and immune response to potential pathogens. It is a complex sy...
متن کاملHuman fecal microbiome-based biomarkers for colorectal cancer.
Colorectal cancer may develop slowly over years from precursor lesions, and thus screening combined with early diagnosis is the key to disease prevention. Recent studies have elucidated specific traits in the gut microbiome associated with colorectal cancer and suggested that the microbiome may be useful in screening for colorectal cancer purposes but failed to provide protocols that can be app...
متن کاملClinical Policy Title: Fecal biomarkers in inflammatory bowel disease
ABOUT THIS POLICY: Prestige Health Choice has developed clinical policies to assist with making coverage determinations. Prestige Health Choice’s clinical policies are based on guidelines from established industry sources, such as the Centers for Medicare & Medicaid Services (CMS), state regulatory agencies, the American Medical Association (AMA), medical specialty professional societies, and p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Deutsches Aerzteblatt Online
سال: 2012
ISSN: 1866-0452
DOI: 10.3238/arztebl.2012.0110a